CNS pipeline · person
Eugene Schneider, MD
Executive Vice President and Chief Clinical Development and Operations Officer of Ionis Pharmaceuticals since September 2023, having joined the company in 2013 and held roles of increasing responsibility in clinical development. He has two decades of clinical development experience, primarily in rare diseases.
- 1 company
Courtesy Ionis Pharmaceuticals
Current roles
- Ionis Pharmaceuticals, Inc.Executive Vice President, Chief Clinical Development and Operations Officer · Executive2023–present
Appears with
People sharing a company with Eugene.
- Allene M. Diaz · Ionis Pharmaceuticals, Inc.
- Brett P. Monia · Ionis Pharmaceuticals, Inc.
- Brian Birchler · Ionis Pharmaceuticals, Inc.
- C. Frank Bennett · Ionis Pharmaceuticals, Inc.
- Elizabeth L. Hougen · Ionis Pharmaceuticals, Inc.
- Eric E. Swayze · Ionis Pharmaceuticals, Inc.
- Holly Kordasiewicz · Ionis Pharmaceuticals, Inc.
- Joan E. Herman · Ionis Pharmaceuticals, Inc.
- Joseph Klein, III · Ionis Pharmaceuticals, Inc.
- Joseph Loscalzo · Ionis Pharmaceuticals, Inc.
- Joseph T. Baroldi · Ionis Pharmaceuticals, Inc.
- Kyle Jenne · Ionis Pharmaceuticals, Inc.
- Ludwig Hantson · Ionis Pharmaceuticals, Inc.
- Michael Hayden · Ionis Pharmaceuticals, Inc.
- Michael Yang · Ionis Pharmaceuticals, Inc.
- Patrick R. O'Neil · Ionis Pharmaceuticals, Inc.
- Peter N. Reikes · Ionis Pharmaceuticals, Inc.
- Shannon L. Devers · Ionis Pharmaceuticals, Inc.
- Spencer R. Berthelsen · Ionis Pharmaceuticals, Inc.
- Stanley T. Crooke · Ionis Pharmaceuticals, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.